Fidelis Capital Partners’s Columbia Research Enhanced Core ETF RECS Stock Holding History
Bought
Maintained
Sold
Other funds holding RECS
GI
BWL
Fidelis Capital Partners's RECS Position: Q1 2026 in Review
Fidelis Capital Partners increased its Columbia Research Enhanced Core ETF (RECS) stake by 14% in Q1 2026, buying an estimated $361K and bringing the position to 73,214 shares worth $2.85M. The position accounts for 0.2% of the portfolio, ranked #95.
Fidelis Capital Partners first reported a position in RECS in Q2 2025 and has held it in 4 quarters since. 175 funds tracked by Wall St. Rank hold RECS as of Q1 2026.
- Fidelis Capital Partners held 73,214 shares of Columbia Research Enhanced Core ETF worth $2.85M as of Q1 2026.
- Fidelis Capital Partners bought 8,899 Columbia Research Enhanced Core ETF shares in Q1 2026, an estimated $361K.
- Columbia Research Enhanced Core ETF made up 0.2% of Fidelis Capital Partners's portfolio in Q1 2026, its #95 holding.
- Fidelis Capital Partners first reported a position in Columbia Research Enhanced Core ETF in Q2 2025 and has held it in 4 quarters since.
- 175 funds tracked by Wall St. Rank held Columbia Research Enhanced Core ETF as of Q1 2026.
Based on Fidelis Capital Partners's 13F filing for Q1 2026, filed 6 May 2026.